Literature DB >> 33183550

Food consumption of branched chain amino acids and insulin resistance: A systematic review of observational studies in humans.

Eduardo Emanuel Sátiro Vieira1, Irislene Costa Pereira1, Amanda Ferraz Braz1, Marcus Vinicius Nascimento-Ferreira2, Lucillia Rabelo de Oliveira Torres3, Aline de Freitas Brito4, Dilina do Nascimento Marreiro5, João Marcelo de Castro E Sousa6, Felipe Cavalcanti Carneiro da Silva6, Francisco Leonardo Torres-Leal7.   

Abstract

This review systematically investigated observational studies in humans that evaluated the dietary intake of branched-chain amino acids (BCAA) and its association with insulin resistance. A search implemented through the electronic databases of PubMed, Scopus, and Web of Science. The evaluation of insulin resistance or the risk of developing insulin resistance in humans were the variables of interest in the search for articles. After using the selection criteria, three studies included in this review. The Food Frequency Questionnaire (FFQ) was the instrument used to evaluate the diet in all of the selected studies. Overall, 1940 studies identified and three thoroughly reviewed. We found only one study with positive effects of BCAA on insulin resistance; the other two reviewed studies did not demonstrate positive effects of the dietary intake of BCAA, individually or the sum of three amino acids on variables of interest. In this sense, the associations between BCAA and insulin resistance are inconsistent, potentially due to other longitudinal outcomes.
Copyright © 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amino acids; Diabetes mellitus; Diet; Insulin resistance; Leucine

Year:  2020        PMID: 33183550     DOI: 10.1016/j.clnesp.2020.09.007

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


  1 in total

1.  Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies.

Authors:  Natthida Sriboonvorakul; Wirichada Pan-Ngum; Kittiyod Poovorawan; Sant Muangnoicharoen; Lauren M Quinn; Bee K Tan
Journal:  J Clin Med       Date:  2021-11-20       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.